Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Bio Key International (BKYI) over the last 16 years, with Q3 2025 value amounting to $75146.0.

  • Bio Key International's Non-Current Deffered Revenue fell 6877.56% to $75146.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75146.0, marking a year-over-year decrease of 6877.56%. This contributed to the annual value of $196237.0 for FY2024, which is 59351.5% up from last year.
  • Bio Key International's Non-Current Deffered Revenue amounted to $75146.0 in Q3 2025, which was down 6877.56% from $96729.0 recorded in Q2 2025.
  • Bio Key International's 5-year Non-Current Deffered Revenue high stood at $240664.0 for Q3 2024, and its period low was $28296.0 during Q4 2023.
  • Its 5-year average for Non-Current Deffered Revenue is $88054.9, with a median of $71037.0 in 2021.
  • In the last 5 years, Bio Key International's Non-Current Deffered Revenue skyrocketed by 64384.62% in 2024 and then plummeted by 6877.56% in 2025.
  • Bio Key International's Non-Current Deffered Revenue (Quarter) stood at $67300.0 in 2021, then fell by 22.53% to $52134.0 in 2022, then plummeted by 45.72% to $28296.0 in 2023, then surged by 593.51% to $196237.0 in 2024, then crashed by 61.71% to $75146.0 in 2025.
  • Its Non-Current Deffered Revenue stands at $75146.0 for Q3 2025, versus $96729.0 for Q2 2025 and $136931.0 for Q1 2025.